Celularity (CELU) Price to Sales (2020 - 2025)

Celularity (CELU) has reported Price to Sales for 6 consecutive years, with 7.8 the latest figure, recorded in Q4 2025.

• On a quarterly basis, Price to Sales fell 91.56% year-over-year to 7.8 in Q4 2025; TTM through Dec 2025 was 1.21, a 30.27% decrease from a year earlier, with the FY2025 full-year figure at 1.21, up 2.81% from the prior year.
• Price to Sales was 7.8 for Q4 2025 at Celularity, down from 11.05 in the prior quarter.
• Over five years, Price to Sales peaked at 202.12 in Q1 2022 and troughed at 3.95 in Q4 2023.
• A 5-year average of 54.25 and a median of 29.4 in 2023 frame the typical range for Price to Sales.
• Across the five-year window, Price to Sales surged 2238.7% in 2024 and tumbled 91.56% in 2025, its largest moves.
• Over 5 years, Price to Sales stood at 70.7 in 2021, then sank by 34.19% to 46.53 in 2022, then sank by 91.51% to 3.95 in 2023, then surged by 2238.7% to 92.42 in 2024, then plunged by 91.56% to 7.8 in 2025.
• The last three Price to Sales figures came in at 7.8 (Q4 2025), 11.05 (Q3 2025), and 10.45 (Q2 2025), per Business Quant data.